Raveendhara R. Bannuru, MD; Tomas Dvorak, MD; Ndidiamaka Obadan, MD, MSc; Winifred W. Yu, MS, RD; Kamal Patel, MPH, MBA; Mei Chung, PhD, MPH; Stanley Ip, MD
Radiation therapy is one of many treatment options for patients with prostate cancer.
To update findings on the clinical and biochemical outcomes of radiation therapies for localized prostate cancer.
MEDLINE (2007 through March 2011) and the Cochrane Central Register of Controlled Trials (2007 through March 2011).
Published English-language comparative studies involving adults with localized prostate cancer who either had first-line radiation therapy or received no initial treatment.
6 researchers extracted information on study design, potential bias, sample characteristics, interventions, and outcomes and rated the strength of overall evidence. Data for each study were extracted by 1 reviewer and confirmed by another.
75 studies (10 randomized, controlled trials [RCTs] and 65 nonrandomized studies) met the inclusion criteria. No RCTs compared radiation therapy with no treatment or no initial treatment. Among the 10 RCTs, 2 compared combinations of radiation therapies, 7 compared doses and fraction sizes of external-beam radiation therapy (EBRT), and 1 compared forms of low-dose rate radiation therapy. Heterogeneous outcomes were analyzed. Overall, moderate-strength evidence consistently showed that a higher EBRT dose was associated with increased rates of long-term biochemical control compared with lower EBRT dose. The body of evidence was rated as insufficient for all other comparisons.
Studies inconsistently defined and reported outcomes. Much of the available evidence comes from observational studies with treatment selection biases.
A lack of high-quality comparative evidence precludes conclusions about the efficacy of radiation treatments compared with no treatments for localized prostate cancer.
Agency for Healthcare Research and Quality.
Is radiation therapy an effective treatment for localized prostate cancer?
This review found inadequate evidence on survival benefits for radiation therapy compared with no treatment for localized prostate cancer. Data on the comparative effectiveness of different radiotherapies was also insufficient, except that higher external-beam radiation therapy (EBRT) dose was associated with better long-term biochemical control than was lower EBRT dose. Radiation therapies sometimes caused urinary or bowel problems, and brachytherapy seemed to be associated with more urinary toxicity than EBRT.
Whether or which radiation treatments improve clinical outcomes for men with localized prostate cancer is unknown.
CENTRAL = Cochrane Central Register of Controlled Trials; RCT = randomized, controlled trial.
Appendix Table 1.
Appendix Table 2.
Appendix Table 3.
The In the Clinic® slide sets are owned and copyrighted by the American College of Physicians (ACP). All text, graphics, trademarks, and other intellectual property incorporated into the slide sets remain the sole and exclusive property of the ACP. The slide sets may be used only by the person who downloads or purchases them and only for the purpose of presenting them during not-for-profit educational activities. Users may incorporate the entire slide set or selected individual slides into their own teaching presentations but may not alter the content of the slides in any way or remove the ACP copyright notice. Users may make print copies for use as hand-outs for the audience the user is personally addressing but may not otherwise reproduce or distribute the slides by any means or media, including but not limited to sending them as e-mail attachments, posting them on Internet or Intranet sites, publishing them in meeting proceedings, or making them available for sale or distribution in any unauthorized form, without the express written permission of the ACP. Unauthorized use of the In the Clinic slide sets will constitute copyright infringement.
Bannuru RR, Dvorak T, Obadan N, et al. Comparative Evaluation of Radiation Treatments for Clinically Localized Prostate Cancer: An Updated Systematic Review. Ann Intern Med. 2011;155:171–178. doi: 10.7326/0003-4819-155-3-201108020-00347
Download citation file:
Published: Ann Intern Med. 2011;155(3):171-178.
Hematology/Oncology, High Value Care, Prostate Cancer.
Results provided by:
Copyright © 2019 American College of Physicians. All Rights Reserved.
Print ISSN: 0003-4819 | Online ISSN: 1539-3704
Conditions of Use